Preview

Артериальная гипертензия

Расширенный поиск

Суточное мониторирование артериального давления в клинической практике: не переоцениваем ли мы его значение?

https://doi.org/10.18705/1607-419X-2004-10-1-5-12

Полный текст:

Аннотация

Амбулаторное суточное мониторирование артериального давления (АД) - СМАД - по праву занимает место одного из крупнейших достижений в кардиологии. Воздавая заслуженную дань очевидным преимуществам этого метода, правомерен вопрос: всегда ли этот недешевый, трудоемкий, обременительный для пациента метод, дающий очень большой объем информации, используется в клинической практике оптимально и всегда ли мы критически относимся к полученным результатам? Многочисленные поперечные и продольные исследования продемонстрировали, что амбулаторное АД теснее, чем клиническое, коррелирует с поражением органов-мишеней и обладает большей прогностической силой для развития сердечно-сосудистых осложнений. Интерпретируя данные этих исследований, следует помнить, что, говоря о клиническом АД, в данном случае имеется в виду среднее значение менее 10 измерений в течение короткого периода времени, в то время как СМАД предоставляет информацию о нескольких десятках измерений АД. Имеются данные и о том, что только у больных с хорошей воспроизводимостью показателей СМАД обнаруживается более тесная по сравнению с клиническим АД корреляция с поражением органов-мишеней. Большинство пациентов с Al' могут наблюдаться с использованием повторных клинических измерений АД или самоконтроля АД. Ho СМАД является средством выбора при оценке пациентов с широкими колебаниями клинического и домашнего АД симптомами гипотонии, эпизодической гипертонией, необъяснимым поражением органов-мишеней. СМАД сохраняет свою ведущую роль для оценки антигипертензивной эффективности новых лекарственных средств в условиях клинических исследований.

Об авторах

Ю. В. Котовская
Российский университет дружбы народов
Россия


Ж. Д. Кобалава
Российский университет дружбы народов
Россия


Список литературы

1. Perlof fD, Sokolow М, Coman К. Tbe prognostic value of ambulatory blood pressure monitoring in treated hypertensive patients. J Hypertens 199I ; 9 (suppl. I): S33-S44.

2. Parati G, Pompidossi O, Albini E et al. Relationship of 24-hour blood pressure mean and variability and severity of target-organ damage in hypertension.J Hyperterts 1987; 5:93-8.

3. Prisant LM, Carrawith AA.Ambulatory blood pressure monitoring and echocar-diograßc ventricular wall thickness and mass. Amer J Hypertens 1990; 3:81 -9.

4. Sibm I, Schroeder P, Aelkjaer C et al. The relation between peripheral vascular structure, lefl ventricular hypertrophy, and ambulatory blood pressure in essential hypertension. Amer J Hypertens 1995; 8:987-96.

5. Staessen JA, Thijs L, Fagard R. et al. for the Systolic Hypertension in Europe Trial Investigators: Predict-ing cardiovascular risk using conventional and ambulatory blood pressure in older patients with systolic bypertension.JAMA 1999; 282: 539-46.

6. Verdecchia P. Prognostic value of ambulatory blood pressure. Currentevidence and clinical implications. Hypertension 2000; 35· 844-51

7. Verdeccbia P, Porcellati C, Schülaci G et al. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793-801.

8. Schmieder RE, Veelken R, Gatzka ChD et al. Predictors for hypertensive nepbropatby: results of a 6-year follow-up study in essential bypertension.J Hypertens 1995; 13:357-65.

9. Khattar RS, Swales JD, Banfleld A et al. Predictionofeomnary and cerebrovascular morbidity and mortality by directeontinuous ambulatory blood pressure monitoring in essential hypertension Circulation 1999; 100:1071-1076.

10. Ohkubo T, Imai Y, Tsuji I et al. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Obasama J Hypertens 1997; 15-357-64-

11. O'Brien E, Atkins N, Staessen J. State of the market. A review of ambulatory blood pressure monitoring devices. Hypertension 1995; 26:835-42.

12. Mancia G, Parati G. Ambulatory blood pressure monitoring and organdarnage. Hypertension 2000:36:894-900.

13. Sega R, Trocino G, LanzarottiA et alAlterations of cardiac structure in patients with isolated office, ambulatory.or home hypertension: data from the general population (PressioneArteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation200l; 104:1385-92.

14. Fagard R, Staessen J, TbijsL Prediction of cardiac structure and function by repeated clinic and ambulatory blood pressure. Hypertension I997; 29- 22 -9-

15. Frigo G, Bertolo O, Roman E et al. Relationship of left ventricular mass urith clinic blood pressure measuredover a six-month period vs. ambulatory blood pressure.J Hypertens 2000; 18 (suppl. 2): S44-

16. Fagard R, Staessen J, Thijs L, AmeryA Multiple standardized clinic bloodpres-sures may predict left ventricular mass as well as ambulatory monitoring. Am J Hypertens 1995; 8:533-40.

17. Palatini P. Too much of a good thing? A critique of overemphasis on the use of ambulatory blood pressure monitoring in clinical practice. JHypertens 2002,-20:1917-23-

18. Joint National Committee on the detection, evaluation, and treatment o fhigh blood pressure. The sixth report of the Joint National Committee onthe detection, evaluation, and treatment of high blood pressure. Arch Intem Med 1997; 157: 2413-46.

19. Guidelines Subcommittee. 1999 World Health Organization -International Society of Hypertension Guidelines for the Management of Hypertension.J Hypertension 1999; 17:151-83-

20. Профилактика, диагностика лечение первичной артериальной гипертонии в Российской Федерации. Первый доклад экспертов научного общества по изучению артериальной гипертонии, Всероссийского научного общества кардиологов и Межведомственного совета по сердечно-сосудистым заболеваниям. Клин. фарм. и тер, 2000; 3:5-30.

21. Рекомендации по профилактике, диагностике иленению артериальной гипертензии. Артериальная гипертензия 2001; 7 (1) (приложение): 4-16.

22. Staessen J, Fagard R, Thijs L,Amery AA consensus view on the technique of ambulatory blood pressure monitoring. Hypertension 1995; 26:912-8.

23. Des Combes BJ, Porchet M, Waeber B,Brunner HR Ambulatory bloodpressure recordings. Reproducibility and unpredictability. Hypertensionl984; 6:110-4.

24. Palatini P, Mormino P, Canali C et al. Factors affecting ambulatory blood pressure reproducibility: results of the HARVEST trial. Hypertension 1994; 23:211-6.

25. Berardi L, Cbati NP, ChanudetX et al. Ambulatory bloodpressure monitoring: a critical review of the current methods to handleoutliers.J Hypertens 1992; 10: 1243-8.

26. Palatini P, Mortnino P, Santonastaso M et al. Ambulatorybloodpressure predicts end organ damage only in subjects withreproducible recordings. J Hypertens 1999; 17:465-73.

27. Mancia G. Ambidatory blood pressure monitoring: research and clinicalappli-cations. J Hypertens 1990; 8 (suppl- 7): SI-S13-

28. Lee DR, Farmer A)’ Swift CG. Jackson SHD. Investigation of ambulatoryblood pressure monitoring data editing criteria JHwn Hypertens 1995/9:195-8.

29. White WB, Lund-Johansen P, Omvik P. Assessment of four ambidatory monitors and measurements by clinicians versus intraarterial blood pressure at

30. Palatini P. Reliability of ambulatory blood pressure monitoring. Blood Press Monit2001; 6: 291-5.

31. National High Blood Pressure Education Coordinating Committee. National High Blood Pressure Education Program working group report on ambulatory blood pressure monitoring. Arch Intern Med 1990; 150:2270-80.

32. American College of Physicians. Automated ambidatory blood pressure and self-measured blood pressure monitoring devices: the role in the diagnosis and management of by pertesion. Ann Intern Med 1993; 118: 889-92.

33. National Institutes of Health. Fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. National Institutes of Health; Bethesda1 MD, 1993.

34. Sheps SG, Clemen tDL, Pickering TG et al. FH. ACC position statement: ambulatory blood pressure monitoring. JAm Coll Cardiol 1994; 23: 1511

35. BloodPressure Measurement Section of the Deutsche Loga zur Bekämpfung des hohen Blutdruckes e. VJ Hum Hypertens 1995; 7: 777-9.

36. Parati G, Bosi S, Castellano M et al. Guidelinesdfor 24h noninvasive ambulatory blood pressure monitoring. Report of the Italian Society of Hypertension. High Blood Pressure 1995; 4:168-74.

37. Pickering TG, Kaplan NM, KrakoffLR et al. American Society of hypertension Expert Panel. Conclusions and recommendations on the clinical use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens 1996; 9-1-11.

38. Wirmicki M, Canali C, Mormino P, Palatini P. Ambulatory bloodpressuremoni-toring editing criteria: Is a standardization needed?Am JHypertens1997; 10: 419-27

39. Verdecchia P,Palatini P, Schülaci G et al. Independent predictors of isotated clinic (white-coaV) bypertension.J Hypertens 2001; 19:1015-20.

40. Bidlingmeyer I, Bumier M, Bidlingmeyer M et al. Isolatedoffice hypertension: a prehypertensive state?J Hypertens 1996; 14:327-32.

41. Glen SK, Elliott HL, Curzio JL et al. White-coat hypertension asa саше of cardiovascular dysfunction.Lancet 1996; 348: 654-7.

42. Hoegholm A, Kristensen KS, Madsen NH, Svendsen TL. White coat hypertension diagnosedby 24-h ambulatory monitoring. Examination of 159 newly diagnosed hypertensive pattents Am J Hypertens 1992; 5·· 64-70.

43. Manda G, Zanchetti A White coat hypertension: misnomers, misconception-sand misunderstandings. What should we do next?J Hypertens 1996; 14: 1049-52.

44. Parati G, Ulian L, Santucciu C et al. Difference betweenelinic and daytime bloodpressure is not a measure of the white coat effect. Hypertension 1998■ 31: 1185-9.

45. Pickering TGJames GD, Boddie C et al. How common is while coat hypertension?JAMA 1988; 259:225-8.

46. Polonia JJ, Santos AR, Gama GM et al. Follow-up clinic and ambulatory blood pressure in untreated white-coat hypertensive patients (evaluation after 2-5 years). Blood Press Monit 1997; 2:289-95.

47. Saito I, Imai Y, Shimada K et al. on behalf of J-MUBA Study Group. Prevalence of and causativefactors in white coat hypertension: results of the Japanese Multi-cebter Study on Bamidipine with Ambulatory blood Pressure Monitoring. Blood PressMonit 200J; 6 (suppl. 2): SI 7-S23.

48. Wittenberg C, Zabłudowski JR, Rosenfeld JB. Overdiagnosis of hypertensionin the elderly.J Hum Hypertens 1992; 6:349-52.

49. Palatini P, Mormino P, Santonastaso M et al. Target organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the Harvest study. Hypertension 1998; 31:5 7-63.

50. Palatini P, Dorigatti F, Roman E et al. White-coat hypertension: a selection bias? Harvest Study Investigators. Hypertension and Ambulatory Recording Venetia Study. J Hypertens 1998; 16:977-84-

51. O'Brien E, Coats A, Owens Petal. Useand interpretation of ambulatory blood pressure monitoring: recommendations of the British Hypertension Society. BMJ 2000; 320:1128-34.

52. O'Brien E,Murhy J, Tynda UA et al. Tiventy-Jour-hour ambulatory blood pressure in men and women aged 17 to 80 years: The Allied hish Bank Study. J. Hypertens 1991; 9:355-60.

53. Staessen J, Fagard R, Lijnen P et al. Reference valuesfor ambulatory hlood pressure: a meta- analysis. J. Hyperiens 1990; 8 (suppl. 6.): S67-S69

54. Mancia G, Sega R, Bravi C et al. Ambulatory blood pressure normality: results of the PAMELA study.J Hyperiens 1995; 13:1377-90.

55. Thijs L, Staessen J, O'Brien E et aL The ambulatory blood pressure in nor-motensive and hypertensive subjects: results from an international database. Netherl J Med 1995; 46:106-14.

56. Weber M, Neutel J, Smith H, Graettinger F. Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Circulation 1994; 90:2291

57. Ohkudo T, Imai Y, Tsuji I et al. Reference valuesfor 24 -hour ambulatory blood pressure monitoring based on a prognostic criterion: The Ohasama Study. / Hypertens 1998; 16 (suppl. 2): S260.

58. Imai Y, Ohkubo T, Tsuji I et al. Prognostic value of home and ambulatory blood pressure measurements in comparison to screening blood pressure measurements: a pilot study inOhasama. Blood Press Monit 1996; I (suppl. 2): S51-S58.

59. Mancia G, Parati G. The role of ambulatory blood pressure monitoring inelderly hypertensive patients. Blood Press Suppl 2000; 2:12-6.

60. Kario K, Pickering TG, Matsuo T et al. Stroke prognosis and abnormal nocturnal blood pressurefalls in olderhyperiensives. Hypertension 2001; 38:852-7.

61. Sander D, Kukla C, Klingelhofer J et al. Relationshipbetween circadian blood pressure patterns and progression of earlycarotid atherosclerosis. A 3 -year follow-up study. Circulation 2000; 102: 15З6-4І.

62. Nakano S, Fukuda Mv Hotta F et al. Reversed circadian blood pressure rlyytbm is associated with occurance of bothfatal and non-fatal vascular events in NlDDM subjects. Diabetes 1998; 47:1501-6.

63. Ohkubo T, Imai Y. Tsuji I et al. Relation between nocturnal decline in blood pressure and mortality. The Ohasarna study. Am,J Hypertem 1997; 10:1201-7.

64. Kikuya V, Hozawa A, Okubo T et al. Prognostic significance of blood pressure and heart rate variability: the Ohasama study. Hypertension 2000; 36:901 -6.

65. Mancia G. Parati G, HenningM et al. on behalf of ELSA investigators. Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclewsis (ELSA)J Hypertens 2001; 19:1981-9-

66. Sleight P, Yusuf S, Ostergren J et al. Comparative effects oframipril on ambula-tory and office blood pressures: a HOPE Substudy. Hypertension 2001; 38: e28.

67. Zanchetti A, Bond M.G., Hennig M. et al. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (EISA), a randomized, doubleblind, long-term trial. Circulation 2002; 106:2422-7-

68. Luders S, Rothemeyer M, Zuehner C et al. Ambulatory blood pressure monitoring (ABPM) vs. Office blood pressure measurement(OM) - A prospective long-term study on the benefits during antilyypertensive treatment. J Hypertens 1998; 16 (suppl. 2): S215.

69. Кабалава Ж.Д., Котовская Ю.В. Мониторирование артериального давления; методические аспекты и клиническое значение. М., 1999; 234 с.


Для цитирования:


Котовская Ю.В., Кобалава Ж.Д. Суточное мониторирование артериального давления в клинической практике: не переоцениваем ли мы его значение? Артериальная гипертензия. 2004;10(1):5-12. https://doi.org/10.18705/1607-419X-2004-10-1-5-12

For citation:


Kotovskaya Y.V., Kobalava Z.D. 24-hour blood pressure monitoring in clinical practice: do we overestimate its value? "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2004;10(1):5-12. (In Russ.) https://doi.org/10.18705/1607-419X-2004-10-1-5-12

Просмотров: 85


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1607-419X (Print)
ISSN 2411-8524 (Online)